Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (901-910 of 1,298) with videos related to

Pageof 130
Sort By:
Nature Communications|May 10, 2020
p85β regulates autophagic degradation of AXL to activate oncogenic signalingLing Rao, Victor C Y Mak, Yuan Zhou, et al.
Cancer Cell|November 16, 2010
Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivationKe Liang, Francisco J Esteva, Constance Albarracin, et al.
Oncotarget|September 28, 2014
Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitorsBurhan Hassan, Argun Akcakanat, Takafumi Sangai, et al.
Nature Communications|February 21, 2014
Genome-wide transcriptome profiling of homologous recombination DNA repairGuang Peng, Curtis Chun-Jen Lin, Wei Mo, et al.
Journal of Inherited Metabolic Disease|March 4, 2017
Mutations in SLC25A22: hyperprolinaemia, vacuolated fibroblasts and presentation with developmental delayEmma S Reid, Hywel Williams, Glenn Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2015
MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian CancerKarina E Hew, Philip C Miller, Dorraya El-Ashry, et al.
Cancer Biology & Therapy|November 8, 2024
The polymeric fluoropyrimidine CF10 overcomes limitations of 5-FU in pancreatic ductal adenocarcinoma cells through increased replication stressJennifer M Finan, Roberto Di Niro, Soon Young Park, et al.
Nature Medicine|August 9, 2011
Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanismsPixu Liu, Hailing Cheng, Stephanie Santiago, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitorsFunda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, et al.
Developmental Cell|October 11, 2007
Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironmentsPatrick T Caswell, Heather J Spence, Maddy Parsons, et al.
Pageof 130

Showing results (901-910 of 1,298) with videos related to

Sort By:
Pageof 130
Nature Communications|May 10, 2020
p85β regulates autophagic degradation of AXL to activate oncogenic signalingLing Rao, Victor C Y Mak, Yuan Zhou, et al.
Cancer Cell|November 16, 2010
Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivationKe Liang, Francisco J Esteva, Constance Albarracin, et al.
Oncotarget|September 28, 2014
Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitorsBurhan Hassan, Argun Akcakanat, Takafumi Sangai, et al.
Nature Communications|February 21, 2014
Genome-wide transcriptome profiling of homologous recombination DNA repairGuang Peng, Curtis Chun-Jen Lin, Wei Mo, et al.
Journal of Inherited Metabolic Disease|March 4, 2017
Mutations in SLC25A22: hyperprolinaemia, vacuolated fibroblasts and presentation with developmental delayEmma S Reid, Hywel Williams, Glenn Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2015
MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian CancerKarina E Hew, Philip C Miller, Dorraya El-Ashry, et al.
Cancer Biology & Therapy|November 8, 2024
The polymeric fluoropyrimidine CF10 overcomes limitations of 5-FU in pancreatic ductal adenocarcinoma cells through increased replication stressJennifer M Finan, Roberto Di Niro, Soon Young Park, et al.
Nature Medicine|August 9, 2011
Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway-dependent and PI3K pathway-independent mechanismsPixu Liu, Hailing Cheng, Stephanie Santiago, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitorsFunda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, et al.
Developmental Cell|October 11, 2007
Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironmentsPatrick T Caswell, Heather J Spence, Maddy Parsons, et al.
Pageof 130